Tissue Factor and Cardiovascular Disease: Quo Vadis?

被引:85
作者
Breitenstein, Alexander [1 ,2 ,3 ]
Tanner, Felix C. [1 ,2 ,3 ]
Luescher, Thomas F. [1 ,2 ,3 ]
机构
[1] Univ Zurich, Inst Physiol, CH-8057 Zurich, Switzerland
[2] Univ Zurich, Ctr Integrat Human Physiol, CH-8057 Zurich, Switzerland
[3] Univ Zurich Hosp, Ctr Cardiovasc, CH-8091 Zurich, Switzerland
基金
瑞士国家科学基金会;
关键词
Cardiovascular diseases; Endothelium; Thrombosis; FACTOR MESSENGER-RNA; FACTOR PATHWAY INHIBITOR; HUMAN ENDOTHELIAL-CELLS; SMOOTH-MUSCLE-CELLS; FACTOR-POSITIVE MICROPARTICLES; FACTOR GENE-EXPRESSION; PROCOAGULANT ACTIVITY; THROMBUS FORMATION; FACTOR-VIIA; TNF-ALPHA;
D O I
10.1253/circj.CJ-09-0818
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The coagulation cascade represents a system of proteases responsible to maintain vascular integrity and to induce rapid clot formation after vessel injury. Tissue factor (TF), the key initiator of the coagulation cascade, binds to factor VIIa and thereby activates factor IX and factor X, resulting in thrombus formation. Different stimuli enhance TF gene expression in endothelial and vascular smooth muscle cells. In addition to these vascular cells, TF has recently been detected in the bloodstream in circulating cells such as leukocytes and platelets, as a component of microparticles, and as a soluble, alternatively spliced form of TF. Various cardiovascular risk factors like hypertension, diabetes, and dyslipidemia, increase levels of TF. In line with this observation, enhanced vascular TF expression occurs during atherogenesis, particularly in patients with acute coronary syndromes. (Circ J 2010; 74: 3-12)
引用
收藏
页码:3 / 12
页数:10
相关论文
共 113 条
[1]   Disulfide isomerization switches tissue factor from coagulation to cell signaling [J].
Ahamed, Jasimuddin ;
Versteeg, Henri H. ;
Kerver, Marjolein ;
Chen, Vivien M. ;
Mueller, Barbara M. ;
Hogg, Philip J. ;
Ruf, Wolfram .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (38) :13932-13937
[2]   DIFFERENTIAL EXPRESSION OF TISSUE FACTOR PROTEIN IN DIRECTIONAL ATHERECTOMY SPECIMENS FROM PATIENTS WITH STABLE AND UNSTABLE CORONARY SYNDROMES [J].
ANNEX, BH ;
DENNING, SM ;
CHANNON, KM ;
SKETCH, MH ;
STACK, RS ;
MORRISSEY, JH ;
PETERS, KG .
CIRCULATION, 1995, 91 (03) :619-622
[3]   Induction of microparticle- and cell-associated intravascular tissue factor in human endotoxemia [J].
Aras, O ;
Shet, A ;
Bach, RR ;
Hysjulien, JL ;
Slungaard, A ;
Hebbel, RP ;
Escolar, G ;
Jilma, B ;
Key, NS .
BLOOD, 2004, 103 (12) :4545-4553
[4]   Tissue-factor antigen and activity in human coronary atherosclerotic plaques [J].
Ardissino, D ;
Merlini, PA ;
Ariens, R ;
Coppola, R ;
Bramucci, E ;
Mannucci, PM .
LANCET, 1997, 349 (9054) :769-771
[5]   Tissue factor encryption [J].
Bach, RR .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (03) :456-461
[6]   Induction of tissue factor expression in human endothelial cells by CD40 ligand is mediated via activator protein 1, nuclear factor κB, and Egr-1 [J].
Bavendiek, U ;
Libby, P ;
Kilbride, M ;
Reynolds, R ;
Mackman, N ;
Schönbeck, U .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (28) :25032-25039
[8]   An inhibitory role of the phosphatidylinositol 3-kinase-signaling pathway in vascular endothelial growth factor-induced tissue factor expression [J].
Blum, S ;
Issbrüker, K ;
Willuweit, A ;
Hehlgans, S ;
Lucerna, M ;
Mechtcheriakova, D ;
Walsh, K ;
von der Ahe, D ;
Hofer, E ;
Clauss, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (36) :33428-33434
[9]   Circulating tissue factor procoagulant activity and thrombin generation in patients with type 2 diabetes: Effects of insulin and glucose [J].
Boden, Guenther ;
Vaidyula, Vijender R. ;
Homko, Carol ;
Cheung, Peter ;
Rao, A. Koneti .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (11) :4352-4358
[10]   Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein [J].
Bogdanov, VY ;
Balasubramanian, V ;
Hathcock, J ;
Vele, O ;
Lieb, M ;
Nemerson, Y .
NATURE MEDICINE, 2003, 9 (04) :458-462